IGX-CDL3

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIGX-CDL3
Drug Alias NameIGX-CDL3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiarrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSynergy Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSynergy Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiarrhea

Other Information

ATC CodeN/A
Related LinksN/A